Diabetic lancing device market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 1,742.01 million and grow at a CAGR of 10.28% in the above-mentioned forecast period. Increasing prevalence of diabetes among the population in developed and developing countries drives the diabetic lancing device market.
Global Diabetic Lancing Device Market, By Type (Safety Lancets, Standard Lancets), Gauge (17/18g, 21g, 23g, 25g, 28g, 30g, Others), Penetration Depth (8 mm to 1.0 mm, 1 mm to 1.5 mm, 6 mm to 2.0 mm, 1 mm to 2.5 mm, 5 mm to 3.0 mm), Application (Hospitals & Clinics, Home Care & Home Diagnostics, Diagnostic Centers & Medical Institutions, Research & Academic Laboratories, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Get Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-diabetic-lancing-device-market
The major players covered in the diabetic lancing device market report are BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Sanofi, Novo Nordisk A/S, Ypsomed Holding, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., ARKRAY USA, Inc., Bayer AG, Amylin Pharmaceuticals Inc., Abbott, Medtronic Inc., Teva Pharmaceuticals Pvt Ltd., Home Diagnostics Inc., Novartis AG, Eli Lilly and Company, Merck & Co., Inc, AstraZeneca, Boehringer Ingelheim International GmbH. and Terumo Corporation among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Report highlights
To analyze the market size of the market and infer the key trends from it.
Major players and brands
Drivers and restrains of the market
Industry Chain Suppliers of Diabetic lancing device market with Contact Information
To inspect the market based on product, market share and size of the product share.
The various opportunities in the market.
Diabetic Lancing Device Market Scope and Market Size
Diabetic lancing device market is segmented on the basis of type, gauge, penetration depth and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
• On the basis of type, diabetic lancing device market is segmented into safety lancets and standard lancets.
• Based on gauge, the diabetic lancing device market is segmented into17/18g, 21g, 23g, 25g, 28g, 30g and others.
• Based on penetration depth, the diabetic lancing device market is segmented into 8 mm to 1.0 mm, 1 mm to 1.5 mm, 6 mm to 2.0 mm, 1 mm to 2.5 mm and 5 mm to 3.0 mm.
• The diabetic lancing device market is also segmented on the basis of application into hospitals & clinics, home care & home diagnostics, diagnostic centers & medical institutions, research & academic laboratories and others.
Key Pointers Covered in the Diabetic Lancing Device Market Industry Trends and Forecast to 2028
• Market Size
• Market New Sales Volumes
• Market Replacement Sales Volumes
• Market By Brands
• Market Procedure Volumes
• Market Product Price Analysis
• Market Regulatory Framework and Changes
• Market Shares in Different Regions
• Recent Developments for Market Competitors
• Market Upcoming Applications
• Market Innovators Study